PER 2.47% 7.9¢ percheron therapeutics limited

News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review, page-38

  1. 11,063 Posts.
    lightbulb Created with Sketch. 993
    Correct. I've seen so many placements over the years where companies pay bottom dollar to get on board. For some reason they always seem reluctant to buy at anything but a discount. How they do it is known only to the directors of the day.... Fortunately it doesn't impact on the potential future success of the company. I console myself with the thought that if they do succeed in making a lot of money, 80% of a very large treasure chest is still way better than 100% of a very small piggy bank. If they don't, then it's situation normal.

    Good fortune all ANP holders
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.9¢
Change
-0.002(2.47%)
Mkt cap ! $81.90M
Open High Low Value Volume
8.0¢ 8.0¢ 7.9¢ $129.2K 1.628M

Buyers (Bids)

No. Vol. Price($)
1 100000 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 335302 4
View Market Depth
Last trade - 11.14am 01/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.